Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

DiaSys and Finggal Link Co., Ltd. Sign an Exclusive Two-Year Sales and Service Agreement for Japan.


Business Editors/Health/Medical Writers

WATERBURY Waterbury, industrial city (1990 pop. 108,961), New Haven co., W Conn., on the Naugatuck River; settled 1674, inc. as a city 1853. The city, once famous for its brass industry, is a financial and commercial center of W Connecticut. , Conn.--(BUSINESS WIRE)--March 26, 2003

DiaSys Corporation (AMEX AMEX

See: American Stock Exchange
:DYX DYX Dyslexia ), a global health-care products company, today announced that it has entered into an exclusive two-year Sales and Service Agreement with Finggal Link Co., Ltd., a subsidiary of Nanbu Nanbu may refer to
  • Nanbu, Aomori, town located in San'nohe District, Aomori, Japan
  • Nanbu, Tottori, town located in Saihaku District, Tottori, Japan
  • Nanbu, Wakayama, town located in Wakayama, Japan
 Irika Corporation. Under the agreement, Finggal Link Co., Ltd will promote, sell and service DiaSys' entire range of clinical laboratory instruments and laboratory consumables in Japan.

Marshall Witzel, DiaSys' CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  said "The expansion of our international distribution network to include Japan is a significant achievement for the new management team of DiaSys. Finggal Link is the ideal partner to implement DiaSys' new aggressive program of expansion and new product development into a previously untapped market."

Masaaki Nagoune, President of Finggal Link Co., Ltd and Nanbu Irika Corporation said: "We are glad to act as the exclusive distributor for DiaSys' unique medical laboratory equipment and consumables for Japan." He further said, " Though we are a small firm, we are the new form of Japanese distributor, providing superior service and support and the ability to react swiftly to ever changing market needs."

Mr. Nagoune further stated: "We are also excited to work with DiaSys to develop new products that showcase our expertise in data processing data processing or information processing, operations (e.g., handling, merging, sorting, and computing) performed upon data in accordance with strictly defined procedures, such as recording and summarizing the financial transactions of a , imaging, and network interface capabilities."

Richard Sledziona, DiaSys' Director of Sales for Pacific Asia said, "We are delighted to welcome Finggal Link to our expanding family of international distributors. Japan currently represents the second largest medical marketplace in the world, and Finggal Link fits our ideal distributor profile perfectly. We are presently working together to register our products for sale in Japan and expect to commence active sales promotion in April, 2003.

About Finggal Link: Finggal Link is the fully-owned subsidiary on Nanbu Irika. Nanbu Irika operates in the Northeast district of Japan as a comprehensive healthcare distributor with an annual turnover of US$49 million. Finggal Link distributes carefully selected, superior products on a nation wide basis, and also develops image analysis and network systems for hospital networks.

About DiaSys: DiaSys Corporation designs, develops, manufacturers and distributes proprietary medical laboratory equipment, consumables and test kits to healthcare laboratories worldwide. Headquartered in Waterbury, CT, the Company operates in Europe through its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 based in Wokingham, England and in Pacific Asia through its strategic business partner based in Guangzhou, China. "DiaSys" "Parasep" and "Urisep" are registered trademarks of DiaSys Corporation.

The foregoing press release includes "forward looking statements" within the meaning of, and made pursuant to, the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:9JAPA
Date:Mar 26, 2003
Words:502
Previous Article:ADVISORY/Spotfire, Biogen, Rosetta to Present Joint Webcast on Building a Complete Microarray Information Management System.
Next Article:Artemis Consolidates Services for GBP 2 Billion of Funds with The Bank of New York; The Bank to Provide Transfer Agency Services to Artemis.
Topics:



Related Articles
Goodyear and Sumitomo form global alliance.
DiaSys and VWR International Sign an Exclusive Two-Year Sales and Service Agreement for Canada.
DiaSys Appoints Exclusive Distributor for Mexico.
DiaSys Corporation Announces Three-Year Renewal of Exclusive Distribution Agreement in China.
DiaSys Announces Three Year Exclusive Distributor Agreement for Sales of Infectious Disease Diagnostics in Pakistan & Afghanistan.
Kadant Black Clawson China obtains Aikawa exclusive.
Malaysia's Public Bank Starts JCB Merchant Acquiring.
Astellas and Toyama Chemical Announce Basic Licensing Agreement on Domestic Marketing and Joint Development of Quinolone Antibiotic T-3811.
JCB Expands Acceptance Network in Austria; Agreement Signed with Europay Austria, a Major Payment Solutions Provider in Central and Eastern Europe.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles